CorMedix Inc. to Report Third Quarter 2024 Financial Results and Provide a Corporate Update on October 30, 2024

GlobeNewswireOct 23 20:30

CorMedix Inc. (CRMD): A Bull Case Theory

Yahoo FinanceOct 23 05:42

CorMedix Is Maintained at Buy by Truist Securities

Dow JonesOct 23 01:26 · Ratings

Cormedix Analyst Ratings

BenzingaOct 23 01:15 · Ratings

Express News | CorMedix Inc : Truist Securities Raises Target Price to $17 From $12

BreakingsOct 22 19:10

CorMedix Stock Trends After New Commercial Agreement With Dialysis Operator: Retail Spirit Stays 'Bullish'

BarchartOct 9 22:42